JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us
このページは機械翻訳されています。他のページは英語で表示される場合があります。 View in English

化学療法 が 悪性 の 産生 器官 に 及ぼす 毒性: 体系 的 な レビュー

  • 01Department of Otorhinolaryngology and Ophthalmology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Republic of Kazakhstan.
Georgian Medical News +

|

2025年8月30日

|

2025年8月30日

PubMedで要約を見る

まとめ

この要約は機械生成です。

化学療法は深刻な眼の問題を引き起こし,がん患者の生活の質に影響を与えます. 早期発見と多科目の治療は 化学療法による眼の毒性の管理と 視力の保全に不可欠です

科学分野

  • 眼科について
  • 腫瘍学
  • 薬理学について

背景

  • 化学療法はがんの生存率を高めますが 眼の毒性を引き起こすことがあります
  • 目の毒性は患者の生活の質 (QoL) を著しく低下させる.

研究 の 目的

  • 化学療法が視覚系に与える影響を分析する.
  • 化学療法による視力低下が QoL に与える影響を評価する.

主な方法

  • 過去10年のRCT,コホート,症例報告の体系的な文献レビュー.
  • パブ・メドやコクラン・ライブラリー ウェブ・オブ・サイエンス スコパスで検索しました
  • 909件の初期製品のデータ抽出と品質評価

主要な成果

  • 化学療法剤は様々な目の毒性:角膜炎,結膜炎,網膜症,視神経症,白内障を引き起こす可能性があります.
  • 治療後数日から数週間の間,視界のぼやけ,視力の変化,眼の痛みが一般的症状です.
  • ソラフェニブのような眼科効果は,早期に特定し,多学科的な管理が必要です.

結論

  • 化学療法による目の毒性はしばしば見過ごされますが,QOLには深刻な影響があります.
  • 早期発見とフォローアップは,重度の視覚障害を予防するために不可欠です.
  • そのメカニズムを理解し 予防戦略を策定するには さらに研究が必要です

関連する概念動画

Cancer Therapies 02:49

7.9K

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Chemotherapy-Induced Nausea and Vomiting: 5-HT<sub>3</sub> Receptor Antagonists 01:27

321

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists 01:28

259

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists 01:29

439

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...

Toxic Reactions: Overview 01:26

1.2K

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...